The Fall of Icarus: Post-psychotic depression - Apropros a clinical case

Introduction Depressive symptoms occur in different phases of psychosis, including prodromal, acute and post-psychotic. Post-psychotic depression (PPD) is a phenomenon that presents as diagnostic therapeutic challenge. Having been ascribed various descriptions the past, PPD has used broad manner to describe depressive appear patients with history psychosis. unveils itself separate nosological entity, differing from adverse effects typically associated antipsychotics, negative other psychiatric disorders present both psychotic (e.g. bipolar disorder, schizoaffective or depression). Objectives The authors case 64 year-old man hospitalized due inaugural psychosis persecutory grandiose delusions well auditory hallucinatory activity, who began develop clinical picture whilst under treatment. A brief discussion on post-psychotic depression, its presentation treatment implications prognosis also presented. Methods non-systematized literature review using Pubmed platform case. Results complaints are common complication episodes, estimating approximately quarter PPD. Although described association schizophrenia, recent describes occurring alongside presentations, first-episode division between affect attempted terms classification, however, blurred lines two continue contribute difficulties differential diagnosis. This becomes challenge when distinguishing extrapyramidal (i.e apathy, abulia alogia) affective-psychotic overlap. only recently considered distinct entity classification systems, research etiology, course, scarce. In regards previously patient, disorder for was identified, through early recognition an antidepressant initiated favourable response. Conclusions relatively which gaining more attention literature. As classifications have begun consider unifying defining criteria, further studies can be developed so clarify aspects remain defined. clinician should aware this potentially confounding symptom provide adequate thus contributing improved patient outcomes. Disclosure Interest None Declared